TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue
- 1 July 1995
- journal article
- Published by Wiley in The Journal of Pathology
- Vol. 176 (3), 299-308
- https://doi.org/10.1002/path.1711760312
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Prostatic carcinoma: a multivariate analysis of prognostic factorsBritish Journal of Cancer, 1994
- Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancerBritish Journal of Cancer, 1993
- Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimensBritish Journal of Cancer, 1993
- p53 Mutations in Human CancersScience, 1991
- The p53 tumour suppressor geneNature, 1991
- Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinomaGenes, Chromosomes and Cancer, 1991
- Allelic loss of chromosomes 16q and 10q in human prostate cancer.Proceedings of the National Academy of Sciences, 1990
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.Molecular and Cellular Biology, 1988
- A Comparative Study of the Peroxidase-antiperoxidase Method and an Avidin-Biotin Complex Method for Studying Polypeptide Hormones with Radioimmunoassay AntibodiesAmerican Journal of Clinical Pathology, 1981